|
|
|
|
|
|
|
M Tue W Th F |
|
27 January, 2026 |
|
|
|
|
|
|
|
|
|
|
in case you missed it
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
|
|
|
|
|
|
|
Roche reported Phase 2 data this morning on one of the assets from its 2023 Carmot deal. Check out Elizabeth Cairns' analysis here on how the drug stacks up against the competition. |
|
|
|
Reynald Castaneda |
Deputy Editor, Endpoints News
|
|
|
|
|
|
